Dr. Paula James

Dr. Paula James in the lab

 

Dr. Paula James is the Graduate Program Director for the Translational Medicine Graduate Program and Professor in the Department of Medicine, with cross-appointments to Pathology & Molecular Medicine and Pediatrics. She joined the Faculty in July of 2004 and is a Clinician Scientist with 75% protected time for research.

Dr. James is a Principal Investigator in the Clinical and Molecular Hemostasis Research Group at Queen’s University with an active basic and clinical research program investigating the genetic basis of inherited bleeding disorders as well as the quantitation of bleeding symptoms. Her group is comprised of post-doctoral fellows, graduate students and well as research associates. In recent years, activities have included validating and publishing the Condensed MCMDM-1VWD Bleeding Questionnaire, which has gained international recognition as well as optimizing a protocol for culturing ECFC (Endothelial Colony Forming Cells) from patients with both inherited and acquired diseases. In May 2015, the Let's Talk Period website and aligned social media accounts were launched to increase knowledge about abnormal bleeding.

In addition to her research activities, Dr. James is the Medical Director of the Southeastern Ontario Inherited Bleeding Disorders Program and was the Medical Director for its aligned Women and Bleeding Disorders Clinic from 2005-2023. She was awarded the Dr. Cecil Harris Award from the Canadian Hemophilia Society in 2017 for distinguished contributions to the field of inherited bleeding disorders.

  • Deputy Head, , ¾ÅÐãÖ±²¥
  • Professor, , Division of Hematology, ¾ÅÐãÖ±²¥
  • Cross-Appointment,
  • Cross-Appointment,
  • Senior Investigator (Adjunct), Blood Research Institute, Blood Center of Wisconsin
  • Regular Attending Staff, Kingston Health Sciences Centre

  • Clinical Investigators Program (June 2004) â€“ Clinical Investigators Program â€“ Royal College of Physicians and Surgeons of Canada (The)
  • Hematology (June 2001) â€“ Hematology â€“ Royal College of Physicians and Surgeons of Canada (The)
  • Internal Medicine (June 1999) â€“ Internal Medicine â€“ University of Saskatchewan
  • Doctor of Medicine (MD) - M.D. (May 1996) â€“ University of Saskatchewan

International
  • 2024-2025   Member of the Medical Program Committee for the WFH 2025 Comprehensive Care Summit to be held in April 2025  
  • 2022-2023   Co-Theme Leader of the subcommittee on Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies for the ISTH 2023 Congress
  • 2021-2022   Co-chair of the Scientific Medical Program Committee for the WFH 2022 World Congress 
  • 2021-2025   Member of the Scientific Committee on Hemostasis for the American Society of Hematology
  • 2020-2022   Member of the World Federation of Hemophilia (WFH) von Willebrand Disease and Rare Bleeding Disorders (VWD-RBD) Committee
  • 2019   Member of the Inherited Bleeding Disorders Sub-Group for the NIH’s Hemostasis Trial Outcomes Working Group
  • 2017   Clinical Co-Chair of the Diagnosis of VWD panel of the ASH ISTH NHF WFH Guidelines on von Willebrand disease
  • 2017   Program co-chair – ASH Consultative Hematology Courses (CHC)
  • 2017   Member of the ISTH SSC Hemophilia and Bleeding (including Transfusion) Scientific Topic Theme Subcommittee for ISTH 2019 Melbourne
  • 2016   Member of the ISTH SSC Hemophilia and Bleeding (including Transfusion) Scientific Topic Theme Subcommittee for ISTH 2019 Melbourne
  • 2015   Von Willebrand Disease and Rare Bleeding Disorders Committee of the WFH
  • 2015   Medical Advisory Committee (MAC) of the Foundation for Women and Girls with Blood Disorders (FWGBD)
  • 2013   Chair of the Scientific Subcommittee for Coagulation Factors and Inhibitors – planning for ISTH 2015 in Toronto
  • 2012-2016   Co-Chair of the von Willebrand Factor Scientific and Standardization Committee (SSC) of ISTH
  • 2010   Member of the ISTH SSC von Willebrand Factor Mutation Database Steering Committee
  • 2008-2016   Member of Global Emerging Hemophilia Expert Panel (GEHEP) - sponsored by Bayer Inc.
National
  • 2018   Chair of the VWD and Research Subcommittees of the Association of Hemophilia Clinic Directors of Canada
  • 2013   Board Member of the Association of Hemophilia Clinic Directors of Canada
  • 2010   Member of the Women and Bleeding Disorders Subcommittee of the AHCDC
Local
  • 2012-2017   Member of the Department of Medicine Accountability Committee
  • 2011-present  Medical Director of the Inherited Bleeding Disorders Clinic of Southeastern Ontario
  • 2010-2018   Member of the Department of Pathology Graduate Program Committee
  • 2009-2021   Co-Director National Hemophilia Mutation Detection Program - Responsible for VWD genetic testing
  • 2014-2018   Member of the Faculty of Health Sciences Student Appeals Board
  • 2005-2023  Medical Director of the Women and Bleeding Disorders Clinic – Kingston General Hospital

  • 2021   Aesculapian Society ¾ÅÐãÖ±²¥ Medical School Lectureship Award
  • 2018   The 2018 Distinguished Service Award - ¾ÅÐãÖ±²¥ Department of Medicine
  • 2018   Best Medicine Grounds Presentation - ¾ÅÐãÖ±²¥ Department of Medicine
  • 2017   The 2017 Dr. Cecil Harris Award - The Canadian Hemophilia Society
  • 2015   The Inaugural Wallace H. Coulter Distringuished Lecture (Nominated) - International Society for Laboratory Hematology
  • 2014   Research Achievement Award - ¾ÅÐãÖ±²¥ Department of Medicine
  • 2012   Basmajian Award for Excellence in Health Sciences Research - Faculty of Health Sciences, ¾ÅÐãÖ±²¥
  • 2011   Researcher of the Year Award of Excellence - National Hemophilia Foundation (US Organization)
  • 2011   Clinician Scientist Development Program Award - Southeastern Ontario Medical Organization
  • 2008   Aesculapian Society ¾ÅÐãÖ±²¥ Medical School Phase IIA Teaching Award
  • 2008   CSL Behring Prof. Heimburger Award - Early Career Investigator Award
  • 2007   Excellence in Research Award, Department of Medicine ¾ÅÐãÖ±²¥
  • 2007   Bayer International Hemophilia Awards - Early Career Investigator Award
  • 2005   Young Investigator Award - International Society of Thrombosis and Hemostasis
  • 2003   John H. Crookston Award - Canadian Hemotology Society
  • 2003   Aventis Behring - CHS - AHCDC Fellowship
  • 2002   Aventis Behring - CHS - AHCDC Fellowship
  • 2000   Ian Holmes Senior Professionalism Award, University of Saskatchewan
  • 1999   Chief Medicine Resident, University of Saskatchewan
  • 1999   Critical Care Award for Excellence, University of Saskatchewan
  • 1998   Third Place, Residents' Research Day, University of Saskatchewan
  • 1994   SAHO Summer Student Externship
  • 1990   Harold and Joyce Dietrich Scholarship, Luther College